NVS logo

NVS Novartis AG

New York Stock Exchange · Drug Manufacturers - General · Healthcare

$151.98
+0.76 (+0.50%)

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic a…

Market Cap: $287.03Bwww.novartis.com

Price

$140.37-12.26%
$137.16$145.80$154.45$163.09
Aug 25Sep 18

Social Signal Score

41
5d
37
9 mentions
+0.0%
30d
48
23 mentions
+0.0%
60d
42
35 mentions
+0.0%
90d
37
80 mentions
-11.2%
news: 80

Analyst Ratings

25 analysts
Holdconsensus
Strong Buy 0Buy 6Hold 17Sell 2Strong Sell 0
Avg price target$149.5-1.6%
Low $136Median $149.5High $163
Current Consensus

52-week range

$121.80$168.62
Last close
$140.37
Off 52w high
-16.8%
200-day average
$150.19
vs 200-day
-6.5%

Compare with other stocks off their highs

Revenue

$15.03B+19.22%
$10.78B$12.20B$13.61B$15.03B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$8.93
$8.59–$9.06
7 analysts
FY2026
$8.91-0% YoY
$8.67–$9.12
7 analysts
FY2027
$9.89+11% YoY
$9.70–$10.16
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Vasant Narasimhan
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
75,267
Beta
0.41
Country
CH
Piotroski score
7 / 9 (Strong)
Altman Z-score
3.48
www.novartis.com